ArticleThe Pan African medical journal2025
Detection frequency of SARS-CoV-2 over the different waves of COVID-19 between 2020 and 2022 in Cameroon.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cameroon faced several waves of COVID-19 epidemics between 2020 and 2022. The epidemic peaks were characterized by variations in the number of positive cases and major variants. The aim of this study was to determine the frequency of COVID-19 in Cameroon during the different epidemic waves. Methods: nasopharyngeal samples were collected in different regions of Cameroon between 2020 and 2022. The Daan Gene kit (DaAn Gene, Guangzhou, Guangdong Province, China) was used to detect SARS-CoV-2 in the samples by RT-PCR assay. Excel 2013 software was used to record participants´ sociodemographic characteristics (age, sex, sampling date) and SARS-CoV-2 test results. Statistical analyses were performed using IBM SPSS version 25 software. Results: from 16 March 2020 to 31 December 2022, 142,850 samples were tested. Participants ranged in age from 1 to 99 years with a M/F sex ratio of 1.32. Of the participants tested, 17,463 (12.2%) were positive for SARS-CoV-2. The SARS-CoV-2 detection rate decreased over time and was highest in 2020 (15.6%; 7255/46466) as opposed to 2021 (12.7%; 8859/69867) and 2022 (5.1%; 1349/26383). Four peaks of COVID-19 circulation were identified: May 2020, March 2021, September 2021 and December 2021. Risk factors for increased detection of SARS-CoV-2 were being older than 65 years and being from the Littoral region. Conclusion: the SARS-CoV-2 positivity rate in Cameroon decreased over the years, probably due to compliance with the barrier measures implemented by the Cameroonian government to reduce transmission rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.